KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-cash Items: 2010-2018

Historic Non-cash Items for Supernus Pharmaceuticals (SUPN) over the last 9 years, with Dec 2018 value amounting to $57.2 million.

  • Supernus Pharmaceuticals' Non-cash Items rose 7.07% to $2.6 million in Q1 2019 from the same period last year, while for Mar 2019 it was $2.6 million, marking a year-over-year increase of 7.07%. This contributed to the annual value of $57.2 million for FY2018, which is 47.27% down from last year.
  • As of FY2018, Supernus Pharmaceuticals' Non-cash Items stood at $57.2 million, which was down 47.27% from $108.5 million recorded in FY2017.
  • In the past 5 years, Supernus Pharmaceuticals' Non-cash Items registered a high of $108.5 million during FY2017, and its lowest value of $626,548 during FY2014.
  • Moreover, its 3-year median value for Non-cash Items was $57.2 million (2018), whereas its average is $55.7 million.
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Non-cash Items plummeted by 55.25% in 2014, and later surged by 7,120.21% in 2017.
  • Supernus Pharmaceuticals' Non-cash Items (Yearly) stood at $626,548 in 2014, then surged by 43.91% to $901,672 in 2015, then surged by 66.69% to $1.5 million in 2016, then spiked by 7,120.21% to $108.5 million in 2017, then tumbled by 47.27% to $57.2 million in 2018.